[go: up one dir, main page]

YU19797A - Farmaceutski preparati na bazi diklofenaka - Google Patents

Farmaceutski preparati na bazi diklofenaka

Info

Publication number
YU19797A
YU19797A YU19797A YU19797A YU19797A YU 19797 A YU19797 A YU 19797A YU 19797 A YU19797 A YU 19797A YU 19797 A YU19797 A YU 19797A YU 19797 A YU19797 A YU 19797A
Authority
YU
Yugoslavia
Prior art keywords
diclofenac
pharmaceutical compositions
compositions based
preparations
drinkable
Prior art date
Application number
YU19797A
Other languages
English (en)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Apr Patent Holder Sa.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apr Patent Holder Sa. filed Critical Apr Patent Holder Sa.
Publication of YU19797A publication Critical patent/YU19797A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Opisani su novi farmaceutski preparati za oralnu primenu koji sadrže diklofenak zajedno sa karbonatima i bikarbonatima alkainih metala i odredjene supstancije koje obezbedjuju aromu. Ovi preparati su sasvim pitki i ne poseduju neprijatan ukus ili druge sporedne efekte.
YU19797A 1996-05-17 1997-05-16 Farmaceutski preparati na bazi diklofenaka YU19797A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000992A IT1283029B1 (it) 1996-05-17 1996-05-17 Composizioni farmaceutiche a base di diclofenac

Publications (1)

Publication Number Publication Date
YU19797A true YU19797A (sh) 1999-07-28

Family

ID=11374276

Family Applications (1)

Application Number Title Priority Date Filing Date
YU19797A YU19797A (sh) 1996-05-17 1997-05-16 Farmaceutski preparati na bazi diklofenaka

Country Status (24)

Country Link
EP (2) EP1159960B1 (sh)
KR (1) KR100441179B1 (sh)
AR (1) AR007165A1 (sh)
AT (2) ATE229801T1 (sh)
AU (1) AU733083B2 (sh)
CA (1) CA2254144C (sh)
DE (2) DE69709349T2 (sh)
DK (2) DK0906092T3 (sh)
EE (1) EE9800400A (sh)
ES (2) ES2187489T3 (sh)
HK (1) HK1043939B (sh)
HR (1) HRP970269A2 (sh)
IT (1) IT1283029B1 (sh)
LT (1) LT4530B (sh)
LV (1) LV12250B (sh)
MA (1) MA24183A1 (sh)
NZ (1) NZ332655A (sh)
PL (1) PL188883B1 (sh)
PT (2) PT1159960E (sh)
SK (1) SK157698A3 (sh)
TW (1) TW505525B (sh)
WO (1) WO1997044023A1 (sh)
YU (1) YU19797A (sh)
ZA (1) ZA974270B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687542B2 (en) 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
DE10207394B4 (de) * 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
JP2008500288A (ja) 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
JO3352B1 (ar) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa صيغ دايكلوفيناك وطرق استخدامه
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
US7939561B2 (en) 2006-02-07 2011-05-10 Apr Applied Pharma Research S.A. Blister packaging for acute pain regimens
US7700125B2 (en) 2006-02-07 2010-04-20 Kowa Pharmaceuticals America, Inc. Moisture resistant container systems for rapidly bioavailable dosage forms
WO2011036114A1 (en) * 2009-09-25 2011-03-31 Novartis Ag Oral pharmaceutical composition comprising diclofenac
EP2704689B1 (en) 2012-04-19 2018-11-28 Glatt AG Taste-masked pharmaceutical compositions containing diclofenac
MX2017015699A (es) * 2015-06-05 2018-12-11 Lupin Ltd Composiciones de acido diclofenaco.
IT201700009711A1 (it) * 2017-01-30 2018-07-30 Applied Pharma Res Sodium free Diclofenac potassium oral solutions Soluzioni orali di Diclofenac potassico prive di sodio
EP3893865A1 (en) 2018-12-14 2021-10-20 Apr Applied Pharma Research S.A. Ready to use diclofenac stick packs
CA3180560A1 (en) 2020-06-10 2021-12-16 Alberto Reiner Bioavailable sugar-based diclofenac formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607339A1 (de) * 1986-03-06 1987-09-10 Merck Patent Gmbh Pharmazeutische zubereitung
EP0466650A2 (en) * 1990-07-11 1992-01-15 Warner-Lambert Company Improvements in non-steroidal anti-inflammatory therapy
DE4120311A1 (de) * 1991-06-20 1992-12-24 Kali Chemie Pharma Gmbh Konservierte pharmazeutische zubereitungen
DE59410143D1 (de) * 1993-09-07 2002-08-01 Gergely Gerhard Modifizierte Kristalle einer festen, essbaren, organischen Säure
JPH10500982A (ja) * 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ 医薬組成物
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs

Also Published As

Publication number Publication date
CA2254144A1 (en) 1997-11-27
DK0906092T3 (da) 2002-04-15
MA24183A1 (fr) 1997-12-31
PT906092E (pt) 2002-06-28
AU733083B2 (en) 2001-05-03
LT4530B (lt) 1999-07-26
LT98160A (en) 1999-03-25
LV12250A (lv) 1999-04-20
DK1159960T3 (da) 2003-03-31
DE69709349T2 (de) 2002-07-25
AR007165A1 (es) 1999-10-13
SK157698A3 (en) 2000-11-07
DE69718077D1 (de) 2003-01-30
KR20000010792A (ko) 2000-02-25
EP0906092A1 (en) 1999-04-07
HRP970269A2 (en) 1998-04-30
PT1159960E (pt) 2003-03-31
ES2187489T3 (es) 2003-06-16
ES2170396T3 (es) 2002-08-01
CA2254144C (en) 2007-11-20
TW505525B (en) 2002-10-11
ITMI960992A1 (it) 1997-11-17
ATE210976T1 (de) 2002-01-15
WO1997044023A1 (en) 1997-11-27
ATE229801T1 (de) 2003-01-15
EP0906092B1 (en) 2001-12-19
HK1043939B (en) 2003-05-16
EP1159960B1 (en) 2002-12-18
IT1283029B1 (it) 1998-04-03
ZA974270B (en) 1998-01-30
PL329919A1 (en) 1999-04-26
EE9800400A (et) 1999-06-15
LV12250B (en) 1999-09-20
DE69709349D1 (de) 2002-01-31
PL188883B1 (pl) 2005-05-31
KR100441179B1 (ko) 2004-11-26
HK1043939A1 (en) 2002-10-04
DE69718077T2 (de) 2003-09-11
EP1159960A1 (en) 2001-12-05
ITMI960992A0 (sh) 1996-05-17
AU3167697A (en) 1997-12-09
NZ332655A (en) 2000-04-28

Similar Documents

Publication Publication Date Title
YU19797A (sh) Farmaceutski preparati na bazi diklofenaka
BR0201714A (pt) Uso de hidroxiflavanonas para encobrir o sabor amargo
PE100598A1 (es) Inhibicion de sabores indeseables en composiciones orales
TW366286B (en) Flavour-masked pharmaceutical compositions
WO2005041924A3 (en) Administration of levodopa and carbidopa
MY116896A (en) Taste of active pharmaceutical ingredients.
ATE324800T1 (de) Primärzusammensetzung enthaltend einen lipophilen,bioaktiven stoff
BR9712783A (pt) Derivados anticonvulsivos úteis no tratamento de doença bipolar manìaco-depressiva
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
NZ534919A (en) Bioactive keratin peptides
DE69910230D1 (de) Paclitaxel enthaltende arzneimittel
DE50107335D1 (de) Käsearoma
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
BR0213379A (pt) Formulação resistente a derramamento de mascaramento de gosto
ATE287264T1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
WO1999044608A8 (en) New use
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
DE69813846T2 (de) Geschmacksmaskierung schlecht schmeckender formulierungen
YU3400A (sh) Nove soli sa blagotvornim organoleptičkim osobinama
DK0797997T3 (da) Anvendelse af peptidiske bradykinin-antagonister til fremstilling af lægemidler
DE69720275D1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
IT1283608B1 (it) Composizione farmaceutica per la terapia orale diuretica ed antiipertensiva.
UA37849A (uk) Гірка настойка "білий туман"